Aims and Scope
Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists.
Eye encourages the submission of original articles covering all aspects of ophthalmology including:
- external eye disease
- oculo-plastic surgery
- orbital and lacrimal disease
- ocular surface and corneal disorders
- paediatric ophthalmology and strabismus
- medical and surgical retina
- cataract and refractive surgery
- ocular oncology
- ophthalmic pathology
- ophthalmic genetics
Submit your next manuscript to Eye and benefit from:
- Expert Editors and editorial team
- Wide exposure and article visibility via nature.com
- Funder compliant open access options available
- Invited comments and reviews to help you stay on top of the research
- Owned by the Royal College of Ophthalmologists, the only UK professional membership body for medically qualified ophthalmologists
- Free advice from Springer Nature’s Research Data Services
- Share your article through SharedIt - Springer Nature’s content-sharing initiative allowing authors and subscribers to share links to view-only, full-text articles from this journal
Our publishing models
Eye is a Transformative Journal (TJ). When research is accepted for publication, authors can choose to publish using either the traditional publishing route OR via immediate gold Open Access.
Eye is actively committed to becoming a fully Open Access journal. We will increase the number of articles we publish OA, with the eventual goal of becoming a fully Open Access journal. A journal that commits to this process is known as a Transformative Journal.
Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route our standard licensing terms will need to be accepted including our self-archiving policies. Those standard licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
The 2020 peer review performance metrics for Eye are shown below:
Average time to decision without external review - 20 days
Average time to decision following external review - 76 days
Article page views - 1,679,412
The 2020 journal citation metrics for Eye are as follows:
2-year Impact Factor*: 3.775
5-year Impact Factor*: 3.899
Immediacy index*: 1.119
Eigenfactor® score*: 0.01295
Article influence score*: 1.138
JCR Rank*: OPHTHALMOLOGY 12/62
Journal Citation Score*: 1.18
*2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2021)
Current Contents/Clinical Medicine
EBSCO Discovery Service
Science Citation Index
Science Citation Index Expanded (SciSearch)
Summon by ProQuest
EBSCO Academic Search
EBSCO Advanced Placement Source
EBSCO Biomedical Reference Collection
EBSCO STM Source
EBSCO TOC Premier
ISSN and eISSN
The international standard serial number (ISSN) for Eye is 0950-222X, and the electronic international standard serial number (eISSN) is 1476-5454.
Eye now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.
Find out more about RSS feeds, how to download an RSS reader and see all the news feeds offered by Springer Nature.